From the new PR today: "Additionally, two patie
Post# of 148175
(Total Views: 562)
Posted On: 04/09/2020 6:50:07 AM
From the new PR today:
"Additionally, two patients at the same Southern California medical center with moderate COVID-19, were treated with leronlimab under an EIND and subsequently revealed clinical improvement."
I didn't know moderate conditions could be given drugs under an EIND. Regardless, lets not gloss over the significance of this. This points to good results from phase 2 trials which would open up the use of lero to a vast majority of hospitalized cases due to COVID-19.
Someone tell BoJo! He's got to be considered at least in moderate condition.
"Additionally, two patients at the same Southern California medical center with moderate COVID-19, were treated with leronlimab under an EIND and subsequently revealed clinical improvement."
I didn't know moderate conditions could be given drugs under an EIND. Regardless, lets not gloss over the significance of this. This points to good results from phase 2 trials which would open up the use of lero to a vast majority of hospitalized cases due to COVID-19.
Someone tell BoJo! He's got to be considered at least in moderate condition.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼